83015-26-3

GPTKB entity

Statements (34)
Predicate Object
gptkbp:instanceOf gptkb:chemical_compound
gptkbp:affects serotonin reuptake
glutamate system
gptkbp:approvedBy gptkb:France
gptkb:Russia
several European and Asian countries
gptkbp:ATCCode N06AX14
gptkbp:CASNumber gptkb:83015-26-3
gptkbp:discoveredBy Laboratoires Servier
gptkbp:hasMolecularFormula C21H25ClN2O4S
gptkbp:hasPotentialForAbuse yes
gptkbp:hasSMILES CC1=CC2=C(C=C1)S(=O)(=O)C3=C(C2)N(C=C3)NCCCCCCC(=O)O.Cl
gptkbp:hasUNII 54B7F4UJ6J
https://www.w3.org/2000/01/rdf-schema#label 83015-26-3
gptkbp:isNotApprovedBy gptkb:FDA_(United_States)
gptkbp:IUPACName 7-[(3-chloro-6-methyl-5,5-dioxo-6,11-dihydro-5H-dibenzo[c,f][1,2]thiazepin-11-yl)amino]heptanoic acid
gptkbp:legalStatus prescription only (varies by country)
gptkbp:meltingPoint 180-184°C
gptkbp:molecularWeight 436.96 g/mol
gptkbp:name gptkb:Tianeptine
gptkbp:PubChem_CID 68878
62098
gptkbp:routeOfAdministration oral
gptkbp:sideEffect nausea
abdominal pain
constipation
drowsiness
gptkbp:synonym gptkb:Coaxil
gptkb:Stablon
gptkb:Tatinol
Tianeptine sodium
gptkbp:usedAs antidepressant
gptkbp:bfsParent gptkb:atomoxetine
gptkbp:bfsLayer 7